Days Set Up
Monday - Friday
Analytic Time

24 hours

Soft Order Code
ANA/ANA2

Test Updated:

Synonyms

Nuclear Antibody Screen
ANA Screen
Connective Tissue Disorder Screen
LE Prep Replacement Assay
Lupus Test Replacement Assay
ANA
ANTI-NUCLEAR ANTIBODY SCREEN

+ See More

Looking to order a test?

We’ve provided helpful links to make ordering easy.

Find a Requisition

All specimens should be accompanied by a requisition.

Submitting Specimens

Learn about how to properly label and where to ship specimens.

Order Kits and Supplies

MLabs provides all the supplies necessary for the collection of specimens.

Test FAQ

Visit our provider FAQ and learn about common questions to ordering tests.

Test Overview

Test Methodology

Multiplex Flow Immunoassay

Test Usage

The ANA screen test detects autoantibodies to 11 clinically relevant antibodies (dsDNA, SS-A, SS-B, Sm, RNP, SmRNP, Scl-70, Jo-1, Centromere B, Ribosomal P, and Chromatin). A negative result means that the patient’s serum shows no reactivity for these common antibodies associated with connective tissue diseases. See also: Extractable Nuclear Antibodies.

Reference Range

Negative

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Specimen Requirements

Offsite Collection Instructions

Collect specimen in SST tube. Centrifuge, aliquot serum into a plastic vial and refrigerate up to 7 days. Please note if ANA by Multiplexed Immunoassay with Reflex to IFA Titer and Pattern is desired (ANA2).

Yellow Top Tube
Normal Volume
0.5 mL serum
Minimum Volume
0.25 mL serum

Billing Information

CPT Code
86038
Pro Fee Code
 
Insurance Auth Info
 
LOINC
ANA 8061-4, ANA2 47383-5

Have More Questions?

Explore our helpful billing resources:

Our High Standard

Quality that sets us apart

As the reference laboratory division of Michigan Medicine's Department of Pathology, MLabs shares the institution's commitment to applying established quality principles to clinical laboratory testing. Like other large organizations in complex, consequential fields, we rely on an established approach to monitor quality throughout the testing process.

LEARN MORE